NJR (NJR)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9, Altman Z 1.4.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company exhibits a robust capital allocation profile with an ROIC of 6.5%, though the DuPont decomposition reveals that equity returns are primarily driven by financial leverage (3.17x) rather than operational efficiency or margin expansion alone, as asset turnover remains modest at 0.27x. Despite this leverage-heavy structure, profitability metrics remain compelling with a net margin of 16.5% and gross margins expanding to 35.7%, supported by double-digit revenue growth of 13.4%. Fundamental integrity appears strong given the high Piotroski F-Score of 6/9 and a negative Beneish M-Score of -2.44, suggesting low earnings manipulation risk alongside consistent financial health indicators.
Valuation sits at a current P/E multiple of 17.0x, which requires contextualization against historical averages and sector peers to determine if the market is pricing in aggressive future growth or acknowledging potential headwinds. While the implied growth rate from revenue figures supports premium multiples, the reliance on leverage for ROE generation introduces sensitivity to interest rate fluctuations that could compress returns if asset turnover fails to improve. The combination of solid margins and growth suggests the stock may be fairly valued only if operational efficiency can scale alongside top-line expansion without eroding the current margin profile.
A notable divergence emerges in insider behavior, with $625,120 in net selling over the last 90 days, which contrasts sharply with the otherwise positive fundamental signals and low manipulation risk scores. This insider outflow warrants scrutiny as a potential signal of management caution regarding future execution or valuation levels, potentially offsetting some confidence derived from the high F-Score and strong revenue trajectory. The interplay between these divergent data points—strong fundamentals versus active insider distribution—creates an ambiguous risk-reward landscape that necessitates careful monitoring of subsequent quarterly results to confirm whether current selling pressure is justified by unseen operational challenges or purely valuation concerns.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like DVY or VPU, the fund manager is mechanically forced to buy or sell NJR shares regardless of NJR's individual fundamentals. We estimate $588M of passive capital is structurally linked to NJR through 8 tracked ETFs. Passive flows have a limited but growing influence on NJR's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in NJR to visualize passive redemption contagion across ETFs and collateral stocks.
If NJR (NJR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NextEra Energy Inc. (NEE) as the most exposed collateral stock, sharing 1 ETFs with NJR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 13 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
NJR Ownership Dynamics
ETFs with Highest NJR Exposure
Float lock-up computed from 13 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
NJR Capital Efficiency
How efficiently does NJR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
NJR converts -32% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 132% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-0.4%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 19 | $56.96 | $1,082.24 |
| 2026-05-12 | 19 | $55.82 | $1,060.58 |
| 2026-05-11 | 1 | $55.55 | $55.55 |
| 2026-05-08 | 1 | $55.53 | $55.53 |
| 2026-04-15 | 1,374 | $56.09 | $77,067.66 |
| 2026-04-07 | 2,000 | $55.84 | $111,680 |
| 2026-04-06 | 2,000 | $55.96 | $111,920 |
| 2026-03-31 | 217 | $55.44 | $12,030.48 |
| 2026-03-26 | 4 | $54.12 | $216.48 |
| 2026-03-20 | 3 | $53.79 | $161.37 |
| 2026-03-18 | 200 | $54.23 | $10,846 |
| 2026-03-12 | 979 | $53.91 | $52,777.89 |
| 2026-03-02 | 186 | $54.24 | $10,088.64 |
| 2026-02-17 | 1,234 | $54.23 | $66,919.82 |
| 2026-02-02 | 29 | $49.48 | $1,434.92 |
| 2025-12-22 | 51 | $46.31 | $2,361.81 |
| 2025-12-02 | 1 | $47.25 | $47.25 |
| 2025-11-28 | 104 | $47.88 | $4,979.52 |
| 2025-11-26 | 104 | $47.88 | $4,979.52 |
| 2025-11-25 | 4 | $48.29 | $193.16 |
| 2025-11-24 | 2 | $48.83 | $97.66 |
| 2025-11-21 | 2 | $48.04 | $96.08 |
| 2025-11-17 | 28 | $46.62 | $1,305.36 |
| 2025-11-07 | 30 | $45.19 | $1,355.7 |
| 2025-10-14 | 304 | $45.13 | $13,719.52 |
| 2025-10-10 | 3 | $46.01 | $138.03 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare NJR to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.